Paper Details

  1. Home
  2. Paper Details

Update on hepatitis C treatment: systematic review of clinical trials.

Author: JhaveriManan, KowdleyKris V, ProcacciniNicholas

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.
Systematic ReviewA review that systematically collects, evaluates, and integrates relevant research to answer a specific research question.

Overview

Chronic hepatitis C is a serious health problem that can lead to liver damage, cirrhosis, and liver cancer. New medications called directly acting antiviral agents (DAAs) have significantly improved treatment, with better tolerability, shorter treatment times, and higher cure rates. This review summarizes recent studies on DAAs for different types of hepatitis C and for people with both HCV and HIV.
Paper Details　
Original Abstract of the Article :
Chronic hepatitis C is a major public health problem. The chronicity of the hepatitis C can lead to advanced liver disease, cirrhosis and even hepatocellular carcinoma. Chronic hepatitis C is the leading indication of for liver transplantation in the United States. Since the introduction of directly...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://pubmed.ncbi.nlm.nih.gov/27768010

データ提供：米国国立医学図書館（NLM）

Hepatitis C Treatment: A New Dawn of Hope

Hepatitis C, a viral infection that can lead to serious liver damage, is a significant health challenge, much like a persistent desert sandstorm. This comprehensive review examines the latest developments in hepatitis C treatment, highlighting the remarkable advances in directly acting antiviral agents (DAAs). The researchers, like skilled desert navigators, chart the progress in hepatitis C treatment, identifying the most effective and well-tolerated therapies.

DAAs: A Breakthrough in Hepatitis C Treatment

The review, like a detailed map of the desert, highlights the transformative impact of DAAs on hepatitis C treatment. These agents have revolutionized treatment, offering shorter treatment durations, higher cure rates, and improved tolerability. This review, encompassing numerous clinical trials, underscores the remarkable progress in hepatitis C therapy, offering hope for patients and a brighter future for liver health.

Hepatitis C: A Journey Towards a Cure

This review, like a refreshing oasis in the desert, provides a beacon of hope for individuals battling hepatitis C. It emphasizes the importance of continued research and development of new therapies, ultimately striving for a cure for this debilitating infection. This review underscores the importance of ongoing efforts to combat infectious diseases and improve patient outcomes.

Dr.Camel's Conclusion

This comprehensive review, like a treasure map leading to a hidden oasis, unveils the remarkable progress in hepatitis C treatment. DAAs, like a powerful camel caravan, have transformed the landscape of hepatitis C management, offering shorter treatment durations, higher cure rates, and improved tolerability. This review is a testament to the power of scientific innovation and the hope for a future free from the burden of hepatitis C.

Date :
  1. Date Completed 2017-09-11
  2. Date Revised 2018-12-02
Further Info :

Pubmed ID

27768010

DOI: Digital Object Identifier

R08Y9999N00A16102102

Related Literature

Article Analysis
・Effective treatment of hepatitis c
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.